Paper10469372
Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
Kato S and 7 others. Kidney Int, 1999. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats. Papers, record 10469372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10469372
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemokine CCL2 | Major topic |
| Diabetes Mellitus, Experimental | Major topic |
| Renin-Angiotensin System | Major topic |
| Angiotensin Receptor Antagonists | |
| Angiotensin-Converting Enzyme Inhibitors | |
| Animals | |
| Base Sequence | |
| Benzimidazoles | |
| Biphenyl Compounds | |
| Cytokines | |
| DNA Primers | |
| Diabetic Nephropathies | |
| Enalapril | |
| Gene Expression | |
| Growth Substances | |
| Kidney Glomerulus | |
| Macrophages | |
| Male | |
| Proteinuria | |
| RNA, Messenger | |
| Rats | |
| Rats, Wistar | |
| Receptor, Angiotensin, Type 1 | |
| Receptor, Angiotensin, Type 2 | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Tetrazoles |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42509486 | Sex-dependent and compartment-specific macrophage accumulation associates with glomerular injury in BTBR ob/ob mice. | Pflugers Arch | 2026 | https://conductscience.org/library/papers/42509486 | PubMed |
| 39457523 | Fiery Connections: Macrophage-Mediated Inflammation, the Journey from Obesity to Type 2 Diabetes Mellitus and Diabetic Kidney Disease. | Biomedicines | 2024 | https://conductscience.org/library/papers/39457523 | PubMed |
| 38673935 | Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38673935 | PubMed |
| 38352948 | The role of innate immunity in diabetic nephropathy and their therapeutic consequences. | J Pharm Anal | 2024 | https://conductscience.org/library/papers/38352948 | PubMed |
| 36564084 | Ethnic differences in urinary monocyte chemoattractant protein-1 and heparanase-1 levels in individuals with type 2 diabetes: the HELIUS study. | BMJ Open Diabetes Res Care | 2022 | https://conductscience.org/library/papers/36564084 | PubMed |
| 36316651 | Efficacy of the monocarbonyl curcumin analog C66 in the reduction of diabetes-associated cardiovascular and kidney complications. | Mol Med | 2022 | https://conductscience.org/library/papers/36316651 | PubMed |
| 36134964 | Hydrolysis of Soybean Milk Protein by Papain: Antioxidant, Anti-Angiotensin, Antigenic and Digestibility Perspectives. | Bioengineering (Basel) | 2022 | https://conductscience.org/library/papers/36134964 | PubMed |
| 35363774 | The role of CDH2 and MCP-1 mRNAs of blood extracellular vesicles in predicting early-stage diabetic nephropathy. | PLoS One | 2022 | https://conductscience.org/library/papers/35363774 | PubMed |
| 35041192 | Cellular crosstalk of glomerular endothelial cells and podocytes in diabetic kidney disease. | J Cell Commun Signal | 2022 | https://conductscience.org/library/papers/35041192 | PubMed |
| 34307308 | The Potential Association between the Risk of Post-Surgical Adhesion and the Activated Local Angiotensin II Type 1 Receptors: Need for Novel Treatment Strategies. | Gastrointest Tumors | 2021 | https://conductscience.org/library/papers/34307308 | PubMed |
| 34199409 | Regulation of Monocytes/Macrophages by the Renin-Angiotensin System in Diabetic Nephropathy: State of the Art and Results of a Pilot Study. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34199409 | PubMed |
| 33139635 | Empagliflozin Inhibits Basal and IL-1β-Mediated MCP-1/CCL2 and Endothelin-1 Expression in Human Proximal Tubular Cells. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33139635 | PubMed |
| 31498850 | CCR2 knockout ameliorates obesity-induced kidney injury through inhibiting oxidative stress and ER stress. | PLoS One | 2019 | https://conductscience.org/library/papers/31498850 | PubMed |
| 31312972 | Uremic Serum Induces Inflammation in Cultured Human Endothelial Cells and Triggers Vascular Repair Mechanisms. | Inflammation | 2019 | https://conductscience.org/library/papers/31312972 | PubMed |
| 28292274 | Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection. | BMC Nephrol | 2017 | https://conductscience.org/library/papers/28292274 | PubMed |
| 25273317 | Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment. | Endocrine | 2015 | https://conductscience.org/library/papers/25273317 | PubMed |
| 24330074 | Inhibition of MAPK-mediated ACE expression by compound C66 prevents STZ-induced diabetic nephropathy. | J Cell Mol Med | 2014 | https://conductscience.org/library/papers/24330074 | PubMed |
| 23116220 | Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model: comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor. | Clin Sci (Lond) | 2013 | https://conductscience.org/library/papers/23116220 | PubMed |
| 22969168 | Inflammation in diabetic nephropathy. | Mediators Inflamm | 2012 | https://conductscience.org/library/papers/22969168 | PubMed |
| 22811597 | Involvement of the intrarenal renin-angiotensin system in experimental models of glomerulonephritis. | J Biomed Biotechnol | 2012 | https://conductscience.org/library/papers/22811597 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10469372
GET https://conductscience.org/api/papers/v1/10469372/cited_by?page=2